192 related articles for article (PubMed ID: 36243702)
1. Antitumor activity of the protein kinase inhibitor 1-(β-D-2'-deoxyribofuranosyl)-4,5,6,7-tetrabromo- 1H-benzimidazole in breast cancer cell lines.
Koronkiewicz M; Kazimierczuk Z; Orzeszko A
BMC Cancer; 2022 Oct; 22(1):1069. PubMed ID: 36243702
[TBL] [Abstract][Full Text] [Related]
2. Deoxynucleosides with benzimidazoles as aglycone moiety are potent anticancer agents.
Koronkiewicz M; Chilmonczyk Z; Kazimerczuk Z; Orzeszko A
Eur J Pharmacol; 2018 Feb; 820():146-155. PubMed ID: 29246854
[TBL] [Abstract][Full Text] [Related]
3. Exploiting the repertoire of CK2 inhibitors to target DYRK and PIM kinases.
Cozza G; Sarno S; Ruzzene M; Girardi C; Orzeszko A; Kazimierczuk Z; Zagotto G; Bonaiuto E; Di Paolo ML; Pinna LA
Biochim Biophys Acta; 2013 Jul; 1834(7):1402-9. PubMed ID: 23360763
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of novel polybrominated benzimidazole derivatives-potential CK2 inhibitors with anticancer and proapoptotic activity.
Łukowska-Chojnacka E; Wińska P; Wielechowska M; Poprzeczko M; Bretner M
Bioorg Med Chem; 2016 Feb; 24(4):735-41. PubMed ID: 26778657
[TBL] [Abstract][Full Text] [Related]
5. Effect of Simultaneous Inhibition of Protein Kinase CK2 and Thymidylate Synthase in Leukemia and Breast Cancer Cells.
Wińska P; Skierka K; Łukowska-Chojnacka E; Koronkiewicz M; Cieśla J; Bretner M
Anticancer Res; 2018 Aug; 38(8):4617-4627. PubMed ID: 30061228
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of Novel Acyl Derivatives of 3-(4,5,6,7-Tetrabromo-1
Chojnacki K; Wińska P; Karatsai O; Koronkiewicz M; Milner-Krawczyk M; Wielechowska M; Rędowicz MJ; Bretner M; Borowiecki P
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200807
[TBL] [Abstract][Full Text] [Related]
7. Discovery of novel pyrazolo[3,4-b]pyridine scaffold-based derivatives as potential PIM-1 kinase inhibitors in breast cancer MCF-7 cells.
Nafie MS; Amer AM; Mohamed AK; Tantawy ES
Bioorg Med Chem; 2020 Dec; 28(24):115828. PubMed ID: 33166925
[TBL] [Abstract][Full Text] [Related]
8. Biological properties and structural study of new aminoalkyl derivatives of benzimidazole and benzotriazole, dual inhibitors of CK2 and PIM1 kinases.
Chojnacki K; Wińska P; Wielechowska M; Łukowska-Chojnacka E; Tölzer C; Niefind K; Bretner M
Bioorg Chem; 2018 Oct; 80():266-275. PubMed ID: 29966873
[TBL] [Abstract][Full Text] [Related]
9. Synergistic Interactions of 5-Fluorouracil with Inhibitors of Protein Kinase CK2 Correlate with p38 MAPK Activation and FAK Inhibition in the Triple-Negative Breast Cancer Cell Line.
Wińska P; Karatsai O; Staniszewska M; Koronkiewicz M; Chojnacki K; Rędowicz MJ
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872257
[TBL] [Abstract][Full Text] [Related]
10. Cell-permeable dual inhibitors of protein kinases CK2 and PIM-1: structural features and pharmacological potential.
Cozza G; Girardi C; Ranchio A; Lolli G; Sarno S; Orzeszko A; Kazimierczuk Z; Battistutta R; Ruzzene M; Pinna LA
Cell Mol Life Sci; 2014 Aug; 71(16):3173-85. PubMed ID: 24442476
[TBL] [Abstract][Full Text] [Related]
11. Synergistic anti-leukemic effects of CK2 inhibitors and pentabromobenzylisothioureas in vitro.
Koronkiewicz M; Chilmonczyk Z; Kazimierczuk Z
Anticancer Res; 2013 Nov; 33(11):4891-9. PubMed ID: 24222126
[TBL] [Abstract][Full Text] [Related]
12. Thieno[2,3-d]pyrimidin-4(3H)-one Derivatives of Benzimidazole as Potential Anti- Breast Cancer (MDA-MB-231, MCF-7) Agents.
Dimov S; Mavrova AT; Yancheva D; Nikolova B; Tsoneva I
Anticancer Agents Med Chem; 2021; 21(11):1441-1450. PubMed ID: 32698751
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and Anticancer Activity of Novel Dual Inhibitors of Human Protein Kinases CK2 and PIM-1.
Wińska P; Wielechowska M; Koronkiewicz M; Borowiecki P
Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514177
[TBL] [Abstract][Full Text] [Related]
14. Induction of cell death in antiestrogen resistant human breast cancer cells by the protein kinase CK2 inhibitor DMAT.
Yde CW; Frogne T; Lykkesfeldt AE; Fichtner I; Issinger OG; Stenvang J
Cancer Lett; 2007 Oct; 256(2):229-37. PubMed ID: 17629615
[TBL] [Abstract][Full Text] [Related]
15. Characterization of HJ-PI01 as a novel Pim-2 inhibitor that induces apoptosis and autophagic cell death in triple-negative human breast cancer.
Zhao YQ; Yin YQ; Liu J; Wang GH; Huang J; Zhu LJ; Wang JH
Acta Pharmacol Sin; 2016 Sep; 37(9):1237-50. PubMed ID: 27397540
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and mechanism of anti-tumor action of new potential CK2 inhibitors toward glioblastoma cells.
Kaminska B; Ellert-Miklaszewska A; Oberbek A; Wisniewski P; Kaza B; Makowska M; Bretner M; Kazimierczuk Z
Int J Oncol; 2009 Nov; 35(5):1091-100. PubMed ID: 19787263
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of experimental HCC growth in mice by use of the kinase inhibitor DMAT.
Sass G; Klinger N; Sirma H; Hashemolhosseini S; Hellerbrand C; Neureiter D; Wege H; Ocker M; Tiegs G
Int J Oncol; 2011 Aug; 39(2):433-42. PubMed ID: 21567083
[TBL] [Abstract][Full Text] [Related]
18. Novel small molecule protein kinase CK2 inhibitors exert potent antitumor effects on T98G and SEGA cells in vitro.
Pucko E; Ostrowski R; Matyja E
Folia Neuropathol; 2019; 57(3):239-248. PubMed ID: 31588710
[TBL] [Abstract][Full Text] [Related]
19. Eco-friendly synthesis of novel cyanopyridine derivatives and their anticancer and PIM-1 kinase inhibitory activities.
Abouzid KAM; Al-Ansary GH; El-Naggar AM
Eur J Med Chem; 2017 Jul; 134():357-365. PubMed ID: 28431341
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, in vitro antiproliferative activity and kinase profile of new benzimidazole and benzotriazole derivatives.
Chojnacki K; Wińska P; Skierka K; Wielechowska M; Bretner M
Bioorg Chem; 2017 Jun; 72():1-10. PubMed ID: 28340404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]